Almol

Contraindications

Severe forms of renal failure, hypophosphatemia, constipation, stenosing lesions of the large intestine, gastrointestinal diseases that require surgical intervention.

Incompatibilities

Slows down (prevents) the absorption of other drugs due to the adsorbing ability of algeldrate.

Undesirable effects

Nausea, with prolonged use, it is possible to develop a deficiency of phosphorus and accumulation of magnesium in the body.

Therapeutic indications

Peptic ulcer of the stomach and duodenum (as part of combination therapy or for the prevention of exacerbation), gastritis, esophagitis, hernia of the esophageal opening of the diaphragm, heartburn, nausea, pain in the stomach after errors in nutrition, alcohol, coffee, nicotine abuse.

Pharmacotherapeutic group

  • Antacids in combinations

Special precautions for storage

At a temperature of 15-25 °C, in a well-sealed container. Storage at temperatures below 0 °C is excluded.

Keep out of reach of children.

The shelf life of the drug Alma2 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

5 ml of suspension for oral administration contains alheldrate 225 mg and magnesium hydroxide 200 mg, in vials of 355 ml.

Nosological classification (ICD-10)

  • K20 Esophagitis
  • K25 Stomach ulcer
  • K26 Duodenal ulcer
  • K29 Gastritis and duodenitis
  • R11 Nausea and vomiting
  • R12 Heartburn

Dosage (Posology) and method of administration

Inside, 20-60 minutes after eating and before going to bed. A single dose is set individually, depending on the indications. The average therapeutic dose is 2-3 hours.spoons 3-4 times a day.

ATC - Anatomical and therapeutic chemical classification

A02AX Antacids in other combinations